3/29/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE(FROM 6-APA ROUTE)(LOT NO:AMX-D-24030855 TO AMX-D-24030859M.MAR-2024 E.FEB-2028) | DALAS BIOTECH LIMITED | 5000 | KGS | 151067.38 | IRAQ | JNPT NHAVA SHEVA SEA |
3/29/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE(FROM 6-APA ROUTE)(LOT NO:AMX-D-24030860 TO AMX-D-24030863M.MAR-2024 E.FEB-2028) | DALAS BIOTECH LIMITED | 2000 | KGS | 62408.17 | IRAQ | JNPT NHAVA SHEVA SEA |
3/28/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE THROUGH 6-APA ROUTE THROUGH ENZYMATIC ROUTE | CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED | 1500 | KGS | 43527.71 | UNITED ARAB EMIRATES | JNPT NHAVA SHEVA SEA |
3/28/2024 | 29411030 | IMPURITIES AMOXYCILLIN, LOT NO- AMOXICILLIN , DOM: JUNE-23 , DOE: MAY-24 (QTY INMG) | CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED | 250 | NOS | 1.98 | Netherland | DELHI AIR |
3/28/2024 | 29411030 | PHARMACEUTICALS PRODUCTS AMOXICILLIN DCII/GRADE 6F (Amoxycillin USP Compacted) (Grade 6F) | PRIME PHARMACEUTICALS PRIVATE LIMITED | 25 | KGS | 1299.01 | ALGERIA | SAHAR AIR |
3/28/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE THROUGH 6-APA ROUTE THROUGH ENZYMATIC ROUTE | CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED | 7000 | KGS | 235849.21 | EGYPT | JNPT NHAVA SHEVA SEA |
3/28/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE THROUGH 6-APA ROUTE THROUGH ENZYMATIC ROUTE | CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED | 1500 | KGS | 43527.71 | UNITED ARAB EMIRATES | JNPT NHAVA SHEVA SEA |
3/28/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE THROUGH 6-APA ROUTE THROUGH ENZYMATIC ROUTE | CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED | 1500 | KGS | 43527.71 | UNITED ARAB EMIRATES | JNPT NHAVA SHEVA SEA |
3/28/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE THROUGH 6-APA ROUTE THROUGH ENZYMATIC ROUTE | CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED | 3000 | KGS | 120330.71 | Vietnam | JNPT NHAVA SHEVA SEA |
3/28/2024 | 29411030 | AMOXYCILLIN TRIHYDRATE THROUGH 6-APA ROUTE THROUGH ENZYMATIC ROUTE | CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED | 4000 | KGS | 148272.89 | South Korea | JNPT NHAVA SHEVA SEA |